Search papers, labs, and topics across Lattice.
MedSSR addresses the scarcity of high-quality medical reasoning data by synthesizing distribution-controllable reasoning questions using rare disease knowledge and leveraging the policy model itself to generate pseudo-labels. This enables a two-stage, intrinsic-to-extrinsic training paradigm: self-supervised RL on the pseudo-labeled synthetic data, followed by supervised RL on the human-annotated real data. Experiments on Qwen and Llama demonstrate that MedSSR outperforms existing methods across ten medical benchmarks, achieving up to +5.93% gain on rare-disease tasks.
Injecting rare disease knowledge into data synthesis and using self-supervised RL on pseudo-labels dramatically improves medical reasoning in LLMs, outperforming existing methods by up to 5.93% on rare disease tasks.
While large language models hold promise for complex medical applications, their development is hindered by the scarcity of high-quality reasoning data. To address this issue, existing approaches typically distill chain-of-thought reasoning traces from large proprietary models via supervised fine-tuning, then conduct reinforcement learning (RL). These methods exhibit limited improvement on underrepresented domains like rare diseases while incurring substantial costs from generating complex reasoning chains. To efficiently enhance medical reasoning, we propose MedSSR, a Medical Knowledge-enhanced data Synthesis and Semi-supervised Reinforcement learning framework. Our framework first employs rare disease knowledge to synthesize distribution-controllable reasoning questions. We then utilize the policy model itself to generate high-quality pseudo-labels. This enables a two-stage, intrinsic-to-extrinsic training paradigm: self-supervised RL on the pseudo-labeled synthetic data, followed by supervised RL on the human-annotated real data. MedSSR scales model training efficiently without relying on costly trace distillation. Extensive experiments on Qwen and Llama demonstrate that our method outperforms existing methods across ten medical benchmarks, achieving up to +5.93% gain on rare-disease tasks. Our code is available at https://github.com/tdlhl/MedSSR.
